GNTA - Genenta Science - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

59.59M

Cash

18.78M

Avg Qtr Burn

-2.801M

Short % of Float

0.04%

Insider Ownership

38.84%

Institutional Own.

7.89%

Qtr Updated

12/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Temferon Details Glioblastoma, Solid tumor/s	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.